Cargando…
Investigation of cell signalings and therapeutic targets in PTPRK-RSPO3 fusion-positive colorectal cancer
INTRODUCTION: Colorectal cancer (CRC) is one of the most deadly and common diseases in the world, accounting for over 881,000 casualties in 2018. The PTPRK-RSPO3 (P:R) fusion is a structural variation in CRC and well known for its ability to activate WNT signaling and tumorigenesis. However, till no...
Autores principales: | Jeong, Jae Heon, Yun, Jae Won, Kim, Ha Young, Heo, Chan Yeong, Lee, Sejoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491571/ https://www.ncbi.nlm.nih.gov/pubmed/36129915 http://dx.doi.org/10.1371/journal.pone.0274555 |
Ejemplares similares
-
Elucidation of Novel Therapeutic Targets for Breast Cancer with ESR1-CCDC170 Fusion
por: Jeong, Jae Heon, et al.
Publicado: (2021) -
Tracing the Origin of the RSPO2 Long-Hair Allele and Epistatic Interaction between FGF5 and RSPO2 in Sapsaree Dog
por: Kang, Mingue, et al.
Publicado: (2022) -
PTPRK, an EGFR Phosphatase, Is Decreased in CeD Biopsies and Intestinal Organoids
por: Nanayakkara, Merlin, et al.
Publicado: (2022) -
A MET-PTPRK kinase-phosphatase rheostat controls ZNRF3 and Wnt signaling
por: Kim, Minseong, et al.
Publicado: (2021) -
The Impact of PTPRK and ROS1 Polymorphisms on the Preeclampsia Risk in Han Chinese Women
por: Li, Huihui, et al.
Publicado: (2021)